Treatment of unresectable or metastatic melanoma in patients ≥12yrs. Adjuvant treatment of cutaneous melanoma in patients with pathologic involvement of regional lymph nodes >1mm who have undergone complete resection, including total lymphadenectomy.
Yervoy (ipilimumab) is a monoclonal antibody used to treat late-stage, metastatic melanoma, a deadly skin cancer. Yervoy is thought to work by allowing the body's immune system to recognize, target, and attack cells in these tumors.
Ipilimumab was approved by the U.S. Food and Drug Administration (FDA) in March 2011, to treat people with late-stage melanoma that has spread or cannot be removed by surgery. It was later approved by the US FDA on October 28, 2015, for stage 3 patients as adjuvant therapy. On February 1, 2012, Health Canada approved ipilimumab for "treatment of unresectable or metastatic melanoma in patients who have failed or do not tolerate other systemic therapy for advanced disease." Ipilimumab was approved in the European Union (EU), for second line treatment of metastatic melanoma in November 2012.
Nivolumab, in combination with ipilimumab is indicated for the treatment of intermediate or poor risk, previously untreated advanced renal cell carcinoma.
Ipilimumab, in combination with nivolumab, is indicated for the treatment of adults and adolescents twelve years and older with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer that has progressed following treatment with a fluoropyrimidine, oxaliplatin, and irinotecan.
Ipilimumab, in combination with nivolumab, is indicated for the treatment of people with hepatocellular carcinoma who have been previously treated with sorafenib.
Ipilimumab, in combination with nivolumab, is indicated for the first-line treatment of adults with metastatic non-small cell lung cancer (NSCLC) whose tumors express PD-L1 (≥1%) as determined by an FDA-approved test.
In October 2020, the U.S. Food and Drug Administration (FDA) approved the combination of nivolumab with ipilimumab for the first-line treatment of adults with malignant pleural mesothelioma that cannot be removed by surgery.
YERVOY (ipilimumab) injection is a prescription medicine, it can be accessed through the Named Patient Program (NPP) for treatment in the countries of Philippines, Vietnam, Ireland, and India. To inquire about the cost price of purchasing YERVOY and arranging delivery to your location, please get in touch with Mr. Rakesh at +91 9910645395 or send an enquiry to info@cancermedicinesnetwork. We assure you of the quality of the product and guarantee delivery in accordance with your specific requirements.
Dear Rakesh and Colleagues,
We are very happy to let you know that, just after three weeks, there is no trace of the sickness anymore: your medicine did the job very well!
We will always remember with great pleasure your warm welcoming in Delhi! We would like to thank you very much and wish you all the best. In the coming future we will be delighted to suggest your company to other patients.
Sir, As a first time buyer of an iported drug I'm imressed with your company in procurement of the drug from Canada through the shipping time of 11 to 12 days is quite long to wait. Mr Rajesh Kanan your coordinator has been very helpful and cooperative to my many queries. He is always responsive to my SMS, Whatsapp, email and phone calls. Hoping that the good trend will continue in the future. There is some miscommunications with the TNT courier with my first delivery. Hope that will be solved in the second delivery.
If the Brand Name medication "YERVOY (ipilimumab) injection" is not approved or unavailable in your country, patients, physicians, and distributors/suppliers have the option to purchase and import it from Verve Biosciences. To begin the process, you can make an enquiry, and we will assist you in calculating the total cost to buy "YERVOY (ipilimumab) injection" online and arrange delivery to your location. To proceed, we will require a prescription from your treating doctor, and in certain countries, an import license may also be necessary. Throughout the process, our Patient Support team will provide guidance and support.
Verve Biosciences offers assistance in importing the anti-cancer medication YERVOY (ipilimumab) injection. To inquire about the total cost of YERVOY (ipilimumab) injection in various countries, including UAE, Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela, as well as Europe (such as Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia), Russia CIS (including Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia), and other countries like Algeria, Mauritius, Uganda, Zimbabwe, Australia, and New Zealand, please reach out to us. We will provide you with the necessary information regarding the pricing and availability of YERVOY (ipilimumab) injection in the desired locations.